ADVL1416: A Phase 1 study of Ramucirumab, a Human Monoclonal Antibody Against the Vascular Endothelial Growth Factor-2 (VEGFR-2) Receptor in Children with Refractory Solid Tumors, including CNS Tumors
- Goldman, Stewart (PD/PI)
Project: Research project